￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How to stop taking adagrasib (Krazati) and possible symptoms and countermeasures after stopping the drug

2026-02-01 22:25:32

Check Details
Which types of genetic mutations are larotrectinib (Vitaika) suitable for patients with?

2026-02-01 22:25:32

Check Details
A guide to safety matters you need to pay attention to when using Seleniso (Silvio)

2026-02-01 22:25:32

Check Details
Analysis of possible health hazards caused by long-term use of Vigabatrin (Okeda)

2026-02-01 22:25:32

Check Details
Analysis of the effect of mobosetinib (Anvili) in the treatment of EGFR exon 20 insertion mutations

2026-02-01 22:25:32

Check Details
Liver function monitoring indicators and methods during tepotinib (Tuodekang) treatment

2026-02-01 22:25:32

Check Details
Is regorafenib (Belvango) a targeted drug or a chemotherapy drug and its mechanism of action?

2026-02-01 22:25:32

Check Details
The efficacy and changes in blood indicators after taking Pazopanib (Victor) for 2 months

2026-02-01 22:25:32

Check Details
Opicapone dose adjustment principles and individualized treatment plans

2026-02-01 22:25:32

Check Details
Causes and countermeasures for increased creatinine after taking Fenelidone (Kesenda)

2026-02-01 22:25:32

Check Details
The specific effect of rasagiline (Azila) on improving Parkinson’s motor symptoms

2026-02-01 22:25:32

Check Details
The latest marketing trends and market sales of Pralsetinib in 2025

2026-02-01 22:25:32

Check Details
Category
相关知识